Bulletin
Investor Alert

press release

Nov. 1, 2021, 9:01 a.m. EDT

A.I. Breakthrough Could Disrupt the $11 Trillion Medical Sector

FN Media Group Presents GlobalInvestmentDaily.com Market Commentary

LONDON, Nov. 1, 2021 /PRNewswire/ -- The $11.9 trillion global healthcare industry is in the early stages of a massive upheaval. Frustrated by a lack of information and reliability from their current insurers – and utterly confusing billing systems that are nearly impossible to navigate – North Americans have begun taking their healthcare into their own hands...and in a powerful way. But one relatively new company in this space – thanks to its powerful Artificial Intelligence platform, strong leadership team and the imminent launch of its new healthcare app – could offer investors the best way to play this growing trend for maximum upside potential.  Mentioned in today's commentary includes :  QuantumScape Corporation /zigman2/quotes/219305490/composite QS +0.44% , The Trade Desk, Inc. /zigman2/quotes/207508089/composite TTD -0.38% , Zoom Video Communications, Inc. /zigman2/quotes/211319643/composite ZM -1.47% , Apple Inc. /zigman2/quotes/202934861/composite AAPL +0.51% , Alphabet Inc. /zigman2/quotes/202490156/composite GOOGL +0.64% .

That company is Treatment.com International  ( TRUE ; TREIF )   a disruptive healthcare technology firm that is harnessing the power of AI to help individuals improve their health through personalized recommendations and insights. Treatment.com is led by its founder and CEO John Fraser – a true healthcare software pioneer who previously founded and led a healthcare IT company that was acquired for $1.2 billion .

Personalized Healthcare Solution for Consumers

Treatment.com's remarkably bright future is thanks in large part to its development of the most personalized, intelligent healthcare AI on the planet.

For five years, Treatment.com's global team of doctors and engineers trained their Treatment's Global Library Of Medicine (GLM) driven AI to think like a doctor...And it was so effective that the University of Minnesota Medical School licensed it to teach and test their medical students.

The company's AI health assistant app – beta releasing to an exclusive group of consumers in Late  2021 – is known as CARA, and it has been designed to help both caregivers and consumers the power to stay on top of their health and the health of their families.

CARA learns from the consumer's medical profile, wearable data and individual tracking data. CARA then leverages the insights and recommendations developed by the company's proprietary AI to build easy and supportive tools to help ensure great health.

The CARA app also offers a comprehensive health and wellness tracking and analytics platform that integrates seamlessly with wearable devices (such as Apple Watch or Fitbit) and should allow the company to efficiently capitalize on the multi-trillion-dollar wellness industry.

CARA allows for personalized, intelligent follow up with consumers. Working with the University of Minnesota Medical School, Treatment.com brought together the best doctors and engineers from around the world to teach CARA how to think like a doctor and provide a more accurate recommendation than any other digital tool on the market.

Eying Multiple Revenue Streams

Despite all the hype around telehealth, medical apps are projected to grow much more quickly over the next half decade, and Treatment.com   is one of the very few companies that is laser focused on this category. It is this rapidly-growing market – and, in particular, the hottest individual segment of that market – that Treatment.com is now emerging.

Compared to other companies in the space – many of which are still privately held – Treatment.com would appear to offer investors an attractive, early-stage investment opportunity in a company that has the potential for significant growth in valuation.

A Multi-Pronged Approach To A New Market

There's no question that a number of attractive opportunities for investment success are now presenting themselves as the $11.9 trillion healthcare industry is upended by massive changes in consumer behavior.

It's important to remember, however, that Treatment.com   is not simply a telemedicine company looking to capitalize on increasing consumer desire for more convenient healthcare options. Instead, Treatment.com's CARA app – powered by its proprietary AI – is a game-changing healthcare solution that comes along at precisely the right time...and delivers powerful, much-sought-after information and care in a way unlike any other company's product is currently capable of.

From an investment standpoint, in addition to the market opportunity and potential comparables in the space, there are additional criteria to consider when evaluating any investment.  When looking to identify the best of these potentially lucrative investment opportunities, investors should focus on those companies that have this edge.

It's critical that a company have an asset that differentiates them from others in the industry.  In the case of Treatment.com International  ( TRUE ; TREIF ) that huge differentiator is the company's 100%-owned, AI-driven engine – its CARA app – which personalizes the caregiving experience in ways none of its competitors is currently capable of.

Other companies leveraging technology to transform entire industries:

Technology is changing everything, from healthcare to transportation and beyond. And not only has Quantumscape (QS) has been an exciting stock for early-in investors to own, but it's built on a foundation that makes every bit of sense in today's EV battery market. Li-ion batteries come with a suite of clear disadvantages, including capacity, peak charge deterioration over time, overheating, and the necessity for serious cooling systems. A huge plus for automakers and consumers alike.

And thanks to this, the most exciting new frontier for EV makers is now the solid-state battery , which uses a solid electrolyte instead of a liquid or polymer and can deliver two to 10 times the energy density of lithium-ion.

Advertising is evolving, as well. And Trade Desk (TTD) is leading the charge. This industry is growing well beyond social media. In fact, by far, the fastest-growing segment of the digital advertising industry is " programmatic advertising ", which promises to put ads directly in front of consumers using high-speed computers and the ultimate in algorithmic science. And Trade Desk is positioning itself to reap the benefits of this fast-growing segment.

Trade Desk is a company that lets advertisers buy digital ads across a multitude of different publishers in an advertising world that has undergone a lot of changes. This upstart has already been one of huge rewards for investors who have stuck with it long enough.

Zoom Video Communications (ZM)

 dramatic rise to popularity during the COVID-19 pandemic highlights the growing need for video communications in not only the workplace, but also in the healthcare sector. By keeping people connected without going into the office, Zoom may have just contributed to helping slow the spread of COVID-19. But it's only just getting started. Zoom Video Communications has already made major waves, even being featured on Saturday Night Live, and now it's eyeing an even bigger market, partnering with healthcare practices. One, in particular, Pike Creek Psychological Center, has used Zoom to consolidate telehealth, phone and chat using zoom. Judi Willetts, Ph.D., the center's co-director

highlighting

 some of its own issues, including connectivity issues, limited functionality with other programs, and more.

From its COVID-19 initiatives to its FitBit product, Alphabet (GOOGL) is committed to helping the world live its healthiest life. Perhaps even more importantly, however, it is working on key technology that will help physicians optimize their time and make better choices along the way.

Google's Care Studio is just one of its healthcare products. It is a brand-new software solution that will help doctors digitize patient records while keeping this important data private and secure. In a blog post, Google explains , "Care Studio streamlines key clinician workflows so that teams can quickly get the information they need to care for patients. It brings together patient records from the multiple EHRs an organization uses – giving clinicians a centralized view of patient data and the ability to search across these records."

Apple (AAPL) is another innovator that has taken on a number of different industries. From physical products to its approach to media and beyond, there's no doubt that Apple is well-deserving of its $2.47 valuation. But it hasn't stopped there. Though say may overlook Apple as a major player in the world of healthcare, its iWatch and associated applications are invaluable tools in monitoring individuals' health.

Apple has taken a great approach to this massive industry. From its efforts to increase access to COVID-19 vaccinations to its Fitness+ app, Apple. is making waves in the future of health. In fact, just recently, the company announced  that it will be expanding Apple Fitness+ services to include a number of new workouts, group sessions and even meditation features.

By. Brandon Foley

** IMPORTANT NOTICE AND DISCLAIMER -- PLEASE READ CAREFULLY! **

This article is a paid advertisement. GlobalInvestmentDaily.com and its owners, managers, employees, and assigns (collectively "the Publisher") is often paid by one or more of the profiled companies or a third party to disseminate these types of communications. In this case, the Publisher has been compensated by Treatment.com International Inc. ("Treatment.com" or "Company") to conduct investor awareness advertising and marketing. Treatment.com paid the Publisher four hundred and fifty thousand US dollars to produce and disseminate four articles profiling the Company. This compensation should be viewed as a major conflict with our ability to be unbiased. 

Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price may likely occur.

This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position. The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser. This communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company's SEC, SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results. This communication is based on information generally available to the public and on interviews with company management, and does not (to the Publisher's knowledge, as confirmed by Treatment.com) contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher cannot guarantee the accuracy or completeness of the information.

SHARE OWNERSHIP . The Publisher owns shares and / or options of the featured company and therefore has an additional incentive to see the featured company's stock perform well. The Publisher does not undertake any obligation to notify the market when it decides to buy or sell shares of the issuer in the market. The Publisher will be buying and selling shares of the featured company for its own profit. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities.

FORWARD LOOKING STATEMENTS . This publication contains forward-looking information which is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ from those projected in the forward-looking statements. Forward looking statements in this publication include, but are not limited to, the size and anticipated growth of the market for the companies' products, the prospects for success of the Company's to be launched health and wellness app – "CARA", the reported scheduled release of CARA, the ability to acquire customers for CARA, and the projected growth and profit margins of the Company's core product offerings.  Factors that could cause results to differ include, but are not limited to, the companies' ability to fund its capital requirements in the near term and long term, the management team's ability to effectively execute its strategy, the degree of success of the launch of CARA, competition, market saturation, pricing pressures, etc. The forward-looking information contained herein is given as of the date hereof and we assume no responsibility to update or revise such information to reflect new events or circumstances, except as required by law.

INDEMNIFICATION/RELEASE OF LIABILITY . By reading this communication, you acknowledge that you have read and understand this disclaimer, and further that to the greatest extent permitted under law, you release the Publisher, its affiliates, assigns and successors from any and all liability, damages, and injury from this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

TERMS OF USE . By reading this communication you agree that you have reviewed and fully agree to the Terms of Use found here http://GlobalInvestmentDaily.com/Terms-of-Use . If you do not agree to the Terms of Use http://GlobalInvestmentDaily.com/Terms-of-Use , please contact GlobalInvestmentDaily.com to discontinue receiving future communications.

INTELLECTUAL PROPERTY . GlobalInvestmentDaily.com is the Publisher's trademark. All other trademarks used in this communication are the property of their respective trademark holders.  The Publisher is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks.

DISCLAIMER:  GlobalInvestmentDaily.com is Source of all content listed above.  FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with GlobalInvestmentDaily.com or any company mentioned herein.  The commentary, views and opinions expressed in this release by GlobalInvestmentDaily.com are solely those of GlobalInvestmentDaily.com and are not shared by and do not reflect in any manner the views or opinions of FNM.  FNM is not liable for any investment decisions by its readers or subscribers.  FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM was not compensated by any public company mentioned herein to disseminate this press release.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Media Contact
e-mail:  editor@financialnewsmedia.com  
U.S. Phone: +1(954)345-0611

Cision
View original content: https://www.prnewswire.com/news-releases/ai-breakthrough-could-disrupt-the-11-trillion-medical-sector-301412641.html

SOURCE GlobalInvestmentDaily.com

COMTEX_396177430/2454/2021-11-01T09:00:30

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright (C) 2021 PR Newswire. All rights reserved

/zigman2/quotes/219305490/composite
US : U.S.: NYSE
$ 20.68
+0.09 +0.44%
Volume: 7.22M
Jan. 14, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$8.74 billion
Rev. per Employee
N/A
loading...
/zigman2/quotes/207508089/composite
US : U.S.: Nasdaq
$ 75.47
-0.29 -0.38%
Volume: 4.79M
Jan. 14, 2022 4:00p
P/E Ratio
77.41
Dividend Yield
N/A
Market Cap
$36.27 billion
Rev. per Employee
$725,420
loading...
/zigman2/quotes/211319643/composite
US : U.S.: Nasdaq
$ 159.72
-2.38 -1.47%
Volume: 4.70M
Jan. 14, 2022 4:00p
P/E Ratio
42.49
Dividend Yield
N/A
Market Cap
$47.60 billion
Rev. per Employee
$884,435
loading...
/zigman2/quotes/202934861/composite
US : U.S.: Nasdaq
$ 173.07
+0.88 +0.51%
Volume: 80.44M
Jan. 14, 2022 4:00p
P/E Ratio
30.87
Dividend Yield
0.51%
Market Cap
$2826.99 billion
Rev. per Employee
$2.38M
loading...
/zigman2/quotes/202490156/composite
US : U.S.: Nasdaq
$ 2,789.61
+17.87 +0.64%
Volume: 1.48M
Jan. 14, 2022 4:00p
P/E Ratio
26.87
Dividend Yield
N/A
Market Cap
$1853.59 billion
Rev. per Employee
$1.77M
loading...

Comtex

Partner Center

Link to MarketWatch's Slice.